BACKGROUND: It is believed that endothelial dysfunction associated with obesity contributes to reduced vascular production of nitric oxide (NO). Weight reduction after bariatric surgery is known to decrease the risk of cardiovascular disease. The purpose of this study was to determine whether bariatric surgery leads to improvement of metabolic markers of endothelial function: serum NO and its precursor (arginine) concentrations in obese patients. METHODS: Serum NO and L-arginine concentrations were measured in 25 morbidly obese patients directly before and 6 months after bariatric surgery. Moreover, selected parameters that may be involved in development of endothelial dysfunction were also studied. Control group consisted of ten healthy individuals with normal body weight. RESULTS: Six months after bariatric surgery, serum NO concentration was approximately 40% higher than before surgery. Surprisingly, serum NO concentration in nonobese controls was essentially similar to obese patients before surgery. In contrast, serum L-arginine concentration was higher in obese patients than in controls and decreased significantly after surgery. The body weight, blood pressure, triacylglycerols, LDL/HDL-cholesterol ratio, insulin, homeostasis model assessment score (HOMA-index), C-reactive protein, and white blood cell count were higher in obese patients as compared with controls and decreased significantly after surgery. CONCLUSIONS: Our results indicate that improvement of insulin resistance, lipidemia, and blood pressure as well as reduction of systemic inflammation after bariatric surgery were associated with the increase of serum NO concentration. We propose that the increase in serum NO concentration contribute to diverse beneficial effects of weight loss after bariatric surgery especially in the context of risk of atherosclerosis.
BACKGROUND: It is believed that endothelial dysfunction associated with obesity contributes to reduced vascular production of nitric oxide (NO). Weight reduction after bariatric surgery is known to decrease the risk of cardiovascular disease. The purpose of this study was to determine whether bariatric surgery leads to improvement of metabolic markers of endothelial function: serum NO and its precursor (arginine) concentrations in obesepatients. METHODS: Serum NO and L-arginine concentrations were measured in 25 morbidly obesepatients directly before and 6 months after bariatric surgery. Moreover, selected parameters that may be involved in development of endothelial dysfunction were also studied. Control group consisted of ten healthy individuals with normal body weight. RESULTS: Six months after bariatric surgery, serum NO concentration was approximately 40% higher than before surgery. Surprisingly, serum NO concentration in nonobese controls was essentially similar to obesepatients before surgery. In contrast, serum L-arginine concentration was higher in obesepatients than in controls and decreased significantly after surgery. The body weight, blood pressure, triacylglycerols, LDL/HDL-cholesterol ratio, insulin, homeostasis model assessment score (HOMA-index), C-reactive protein, and white blood cell count were higher in obesepatients as compared with controls and decreased significantly after surgery. CONCLUSIONS: Our results indicate that improvement of insulin resistance, lipidemia, and blood pressure as well as reduction of systemic inflammation after bariatric surgery were associated with the increase of serum NO concentration. We propose that the increase in serum NO concentration contribute to diverse beneficial effects of weight loss after bariatric surgery especially in the context of risk of atherosclerosis.
Authors: Camila Puzzi de Carvalho; Daniela Miguel Marin; Aglécio Luiz de Souza; José Carlos Pareja; Elintom Adami Chaim; Silvia de Barros Mazon; Conceição Aparecida da Silva; Bruno Geloneze; Elza Muscelli; Sarah Monte Alegre Journal: Obes Surg Date: 2008-09-25 Impact factor: 4.129
Authors: Maria Raitakari; Thomas Ilvonen; Markku Ahotupa; Terho Lehtimäki; Aimo Harmoinen; Pauli Suominen; Juhani Elo; Jaakko Hartiala; Olli T Raitakari Journal: Arterioscler Thromb Vasc Biol Date: 2003-12-01 Impact factor: 8.311
Authors: Tomasz Sledzinski; Elzbieta Goyke; Ryszard Tomasz Smolenski; Zbigniew Sledzinski; Julian Swierczynski Journal: Obes Surg Date: 2011-10 Impact factor: 4.129
Authors: Eva Pardina; Roser Ferrer; Juan Antonio Baena-Fustegueras; Albert Lecube; Jose Manuel Fort; Víctor Vargas; Roberto Catalán; Julia Peinado-Onsurbe Journal: Obes Surg Date: 2010-05 Impact factor: 4.129
Authors: Andreea Oana Mocanu; Anny Mulya; Hazel Huang; Olivia Dan; Hideharu Shimizu; Esam Batayyah; Stacy A Brethauer; Anca Dinischiotu; John P Kirwan Journal: PLoS One Date: 2015-10-05 Impact factor: 3.240
Authors: Ehab Bakbak; Daniella C Terenzi; Justin Z Trac; Hwee Teoh; Adrian Quan; Stephen A Glazer; Ori D Rotstein; Mohammed Al-Omran; Subodh Verma; David A Hess Journal: Rev Endocr Metab Disord Date: 2021-07-06 Impact factor: 6.514